Ultrasound features suspicious for malignancy predict the risk of BRAF mutation in papillary thyroid carcinoma

被引:0
|
作者
Wang, Shuntao [1 ]
Liu, Zeming [1 ]
Sun, Shiran [1 ]
Li, Xiaoyu [1 ]
Zeng, Wen [3 ]
Xiong, Yiquan [1 ]
Guo, Yawen [1 ]
Wang, Juntao [4 ]
Wang, Yu [2 ]
Liu, Chunping [1 ]
Huang, Tao [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Breast & Thyroid Surg, Union Hosp, Wuhan 430071, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Ultrasound, Union Hosp, Wuhan, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Ophthalmol, Wuhan, Hubei, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Peoples R China
关键词
Ultrasound features; BRAF mutation; papillary thyroid carcinoma; V600E MUTATION; SONOGRAPHIC FEATURES; NODULES; ASSOCIATION; CANCER;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: This study aimed to evaluate the BRAF mutation status in papillary thyroid carcinoma (PTC) on the basis of ultrasound (US) features suspicious for malignancy. Methods: The clinical, pathologic, and radiologic characteristics of patients who were diagnosed with PTC from August 2014 to August 2015 were reviewed. A radiologist who was blinded to the BRAF status, independently reviewed all existing preoperative US examinations and recorded the sonographic characteristics for each PTC case. The US features included echogenicity, composition, height and width, margin, shape, capsule, vascularity, calcification, and number. Univariate and multivariate analyses were performed to determine sonographic predictors. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for each US characteristic that was suspicious for malignancy were calculated. The diagnostic accuracies for predictors of BRAF mutation were calculated via receiver operating characteristic analysis. Results: There was a significant association between echogenicity, composition, height, width, margin, shape, and calcification and BRAF mutation status. However, no association was observed between capsule, vascularity, and number and BRAF mutation status. Poorly defined margins and microcalcification were independent predictors of BRAF mutation via multivariate analysis. PTC with poorly defined margins predicted BRAF mutations with 86.4% sensitivity, 55.0% specificity, and 76.6% accuracy, while microcalcification predicted BRAF mutation with 84.1% sensitivity, 50.0% specificity, and 73.4% accuracy. Conclusions: Poorly defined margins and preoperative microcalcification could effectively predict the BRAF mutation status and provide a valuable guideline for aggressive treatment in PTC. Further investigations should be performed to understand the association between US features and BRAF mutation.
引用
收藏
页码:9470 / 9475
页数:6
相关论文
共 50 条
  • [41] Braf V600E mutation analysis in low and intermediate risk papillary thyroid carcinoma
    Lopez Villar, I.
    Navarro Martinez, T.
    Jane Soler, P.
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Perez Iruela, J.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S71 - S72
  • [42] Midkine expression is associated with clinicopathological features and BRAF mutation in papillary thyroid cancer
    Hua Shao
    Xiaohui Yu
    Cuifang Wang
    Qiang Wang
    Haixia Guan
    Endocrine, 2014, 46 : 285 - 291
  • [43] Midkine expression is associated with clinicopathological features and BRAF mutation in papillary thyroid cancer
    Shao, Hua
    Yu, Xiaohui
    Wang, Cuifang
    Wang, Qiang
    Guan, Haixia
    ENDOCRINE, 2014, 46 (02) : 285 - 291
  • [44] Correlation between BRAF V600E mutation and clinicopathological features in pediatric papillary thyroid carcinoma
    Geng, Jiangqiao
    Wang, Huanmin
    Liu, Yuanhu
    Tai, Jun
    Jin, Yaqiong
    Zhang, Jie
    He, Lejian
    Fu, Libing
    Qin, Hong
    Song, Yingluan
    Su, Jinzhu
    Zhang, Aiying
    Wen, Xin
    Guo, Yongli
    Ni, Xin
    SCIENCE CHINA-LIFE SCIENCES, 2017, 60 (07) : 729 - 738
  • [45] Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma
    Shi, C. L.
    Sun, Y.
    Ding, C.
    Lv, Y. C.
    Qin, H. D.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 7377 - 7385
  • [46] Papillary Thyroid Carcinoma BRAF Immunopositivity
    Erickson, Lori A.
    Chen, Beiyun
    MAYO CLINIC PROCEEDINGS, 2021, 96 (01) : 267 - 268
  • [47] BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography
    Chai, Young Jun
    Kim, Su-jin
    Kim, Soo Chin
    Koo, Do Hoon
    Min, Hye Sook
    Lee, Kyu Eun
    Kim, Ji-hoon
    Youn, Yeo-Kyu
    CLINICAL ENDOCRINOLOGY, 2014, 81 (03) : 432 - 439
  • [48] Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
    Hahn, Soo Yeon
    Kim, Tae Hyuk
    Ki, Chang Seok
    Kim, Sun Wook
    Ahn, Soohyun
    Shin, Jung Hee
    Chung, Jae Hoon
    ONCOTARGET, 2017, 8 (65) : 108946 - 108957
  • [49] Sunitinib inhibits papillary thyroid carcinoma with RET/PTC rearrangement but not BRAF mutation
    Jeong, Woo-Jin
    Mo, Ji-Hun
    Park, Min Woo
    Choi, Ik Joon
    An, Soo-Youn
    Jeon, Eun-Hee
    Ahn, Soon-Hyun
    CANCER BIOLOGY & THERAPY, 2011, 12 (05) : 458 - 465
  • [50] BRAF mutation in progression and therapy of melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma
    Zalesna, Izabela
    Hartman, Mariusz L.
    Czyz, Malgorzata
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 471 - 488